Skip to main content
. 2022 Aug 18;13:4855. doi: 10.1038/s41467-022-32573-w

Fig. 1. Study design and population characteristics.

Fig. 1

a Study design including follow-up timepoints, evaluated immune responses and clinical characteristics of the overall study population (total n = 431). b Evaluated immune responses and clinical characteristics of the subsample of participants selected to cover the spectrum of the infected population (total n = 64). Source data are provided as a Source Data file.